{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T10:17:08Z","timestamp":1776593828240,"version":"3.51.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Poor medication adherence is an extraordinarily common problem worldwide that contributes to inadequate control of many chronic diseases, including Hypertension (HT). Globally, less than 14% of the estimated 1.4 billion patients with HT achieve optimal control. A myriad of barriers, across patient, healthcare provider, and system levels, contributes to poor medication adherence. Few studies have explored the reasons for poor medication adherence in Tanzania and other African countries.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A qualitative study applying grounded theory principles was conducted in the catchment area of two semi-urban clinics in Dar es Salaam, Tanzania, to determine the perceived barriers to HT medication adherence. Ten key informant interviews were conducted with healthcare providers who manage HT patients. Patients diagnosed with HT (SBP\u2009\u2265\u2009140 and DBP\u2009\u2265\u200990), were randomly selected from patient registers, and nine focus group discussions were conducted with a total 34 patients. Inductive codes were developed separately for the two groups, prior to analyzing key thematic ideas with smaller sub-categories.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Affordability of antihypertensive medication and access to care emerged as the most important barriers. Fee subsidies for treatment and medication, along with health insurance, were mentioned as potential solutions to enhance access and adherence. Patient education and quality of physician counseling were mentioned by both providers and patients as major barriers to medication adherence, as most patients were unaware of their HT and often took medications only when symptomatic. Use of local herbal medicines was mentioned as an alternative to medications, as they were inexpensive, available, and culturally acceptable. Patient recommendations for improving adherence included community-based distribution of refills, SMS text reminders, and family support. Reliance on religious leaders over healthcare providers emerged as a potential means to promote adherence in some discussions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Effective management of hypertensive patients for medication adherence will require several context-specific measures. These include policy measures addressing financial access, with medication subsidies for the poor and accessible distribution systems for medication refill; physician measures to improve health provider counseling for patient centric care; and patient-level strategies with reminders for medication adherence in low resource settings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-021-06858-7","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T08:04:51Z","timestamp":1629273891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Patient and healthcare provider perspectives on adherence with antihypertensive medications: an exploratory qualitative study in Tanzania"],"prefix":"10.1186","volume":"21","author":[{"given":"Anbrasi","family":"Edward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brady","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Manase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"issue":"6","key":"6858_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441\u201350. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018912.","journal-title":"Circulation"},{"issue":"7","key":"6858_CR2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","volume":"124","author":"M Burnier","year":"2019","unstructured":"Burnier M, Egan BM. Adherence in hypertension. Circ Res. 2019;124(7):1124\u201340. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313220.","journal-title":"Circ Res"},{"issue":"1","key":"6858_CR3","doi-asserted-by":"publisher","first-page":"e84238","DOI":"10.1371\/journal.pone.0084238","volume":"9","author":"R Khatib","year":"2014","unstructured":"Khatib R, Schwalm JD, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One. 2014;9(1):e84238. https:\/\/doi.org\/10.1371\/journal.pone.0084238.","journal-title":"PLoS One"},{"issue":"11","key":"6858_CR4","doi-asserted-by":"publisher","first-page":"e018829","DOI":"10.1136\/bmjopen-2017-018829","volume":"7","author":"SW Galson","year":"2017","unstructured":"Galson SW, Staton CA, Karia F, Kilonzo K, Lunyera J, Patel UD, et al. Epidemiology of hypertension in northern Tanzania: a community-based mixed-methods study. BMJ Open. 2017;7(11):e018829. https:\/\/doi.org\/10.1136\/bmjopen-2017-018829.","journal-title":"BMJ Open"},{"issue":"1","key":"6858_CR5","doi-asserted-by":"publisher","first-page":"1321279","DOI":"10.1080\/16549716.2017.1321279","volume":"10","author":"NR Mosha","year":"2017","unstructured":"Mosha NR, Mahande M, Juma A, Mboya I, Peck R, Urassa M, et al. Prevalence, awareness and factors associated with hypertension in north West Tanzania. Glob Health Action. 2017;10(1):1321279. https:\/\/doi.org\/10.1080\/16549716.2017.1321279.","journal-title":"Glob Health Action"},{"issue":"1","key":"6858_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/1471-2458-8-407","volume":"8","author":"P Bovet","year":"2008","unstructured":"Bovet P, Gervasoni JP, Mkamba M, Balampama M, Lengeler C, Paccaud F. Low utilization of health care services following screening for hypertension in Dar Es Salaam (Tanzania): a prospective population-based study. BMC Public Health. 2008;8(1):407. https:\/\/doi.org\/10.1186\/1471-2458-8-407.","journal-title":"BMC Public Health"},{"issue":"6","key":"6858_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/jhh.2012.59","volume":"27","author":"M Dewhurst","year":"2013","unstructured":"Dewhurst M, Dewhurst F, Gray W, Chaote P, Orega G, Walker R. The high prevalence of hypertension in rural-dwelling Tanzanian older adults and the disparity between detection, treatment and control: a rule of sixths? J Hum Hypertens. 2013;27(6):374\u201380. https:\/\/doi.org\/10.1038\/jhh.2012.59.","journal-title":"J Hum Hypertens"},{"issue":"9841","key":"6858_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0140-6736(12)60861-7","volume":"380","author":"MM Ibrahim","year":"2012","unstructured":"Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380(9841):611\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(12)60861-7.","journal-title":"Lancet"},{"key":"6858_CR9","unstructured":"World Health Orgnization. Adherence to long-term therapies: evidence for action: World Health Organization; 2003."},{"issue":"4","key":"6858_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/01.hco.0000126978.03828.9e","volume":"19","author":"M Krousel-Wood","year":"2004","unstructured":"Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19(4):357\u201362. https:\/\/doi.org\/10.1097\/01.hco.0000126978.03828.9e.","journal-title":"Curr Opin Cardiol"},{"issue":"jul09 1","key":"6858_CR11","doi-asserted-by":"publisher","first-page":"e3953","DOI":"10.1136\/bmj.e3953","volume":"345","author":"IJ Marshall","year":"2012","unstructured":"Marshall IJ, Wolfe CD, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012;345(jul09 1):e3953. https:\/\/doi.org\/10.1136\/bmj.e3953.","journal-title":"BMJ"},{"issue":"2","key":"6858_CR12","doi-asserted-by":"publisher","first-page":"e0192942","DOI":"10.1371\/journal.pone.0192942","volume":"13","author":"D Bintabara","year":"2018","unstructured":"Bintabara D, Mpondo BCT. Preparedness of lower-level health facilities and the associated factors for the outpatient primary care of hypertension: evidence from Tanzanian national survey. PLoS One. 2018;13(2):e0192942. https:\/\/doi.org\/10.1371\/journal.pone.0192942.","journal-title":"PLoS One"},{"issue":"9","key":"6858_CR13","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/HJH.0b013e328362bad7","volume":"31","author":"RN Peck","year":"2013","unstructured":"Peck RN, Green E, Mtabaji J, Majinge C, Smart LR, Downs JA, et al. Hypertension-related diseases as a common cause of hospital mortality in Tanzania: a 3-year prospective study. J Hypertens. 2013;31(9):1806\u201311. https:\/\/doi.org\/10.1097\/HJH.0b013e328362bad7.","journal-title":"J Hypertens"},{"issue":"7","key":"6858_CR14","doi-asserted-by":"publisher","first-page":"e0130193","DOI":"10.1371\/journal.pone.0130193","volume":"10","author":"J Iwelunmor","year":"2015","unstructured":"Iwelunmor J, Plange-Rhule J, Airhihenbuwa CO, Ezepue C, Ogedegbe O. A narrative synthesis of the health systems factors influencing optimal hypertension control in sub-Saharan Africa. PLoS One. 2015;10(7):e0130193. https:\/\/doi.org\/10.1371\/journal.pone.0130193.","journal-title":"PLoS One"},{"issue":"5","key":"6858_CR15","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/S2214-109X(14)70033-6","volume":"2","author":"R Peck","year":"2014","unstructured":"Peck R, Mghamba J, Vanobberghen F, Kavishe B, Rugarabamu V, Smeeth L, et al. Preparedness of Tanzanian health facilities for outpatient primary care of hypertension and diabetes: a cross-sectional survey. Lancet Glob Health. 2014;2(5):e285\u201392. https:\/\/doi.org\/10.1016\/S2214-109X(14)70033-6.","journal-title":"Lancet Glob Health"},{"issue":"10","key":"6858_CR16","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1093\/heapol\/czw080","volume":"31","author":"A Murphy","year":"2016","unstructured":"Murphy A, Jakab M, McKee M, Richardson E. Persistent low adherence to hypertension treatment in Kyrgyzstan: how can we understand the role of drug affordability? Health Policy Plan. 2016;31(10):1384\u201390. https:\/\/doi.org\/10.1093\/heapol\/czw080.","journal-title":"Health Policy Plan"},{"issue":"1","key":"6858_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s43044-020-00066-0","volume":"72","author":"A Hussein","year":"2020","unstructured":"Hussein A, Awad MS, Mahmoud HEM. Patient adherence to antihypertensive medications in upper Egypt: a cross-sectional study. Egypt Heart J. 2020;72(1):29. https:\/\/doi.org\/10.1186\/s43044-020-00066-0.","journal-title":"Egypt Heart J"},{"key":"6858_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/PPA.S235517","volume":"14","author":"S Mahmood","year":"2020","unstructured":"Mahmood S, Jalal Z, Hadi MA, Orooj H, Shah KU. Non-adherence to prescribed Antihypertensives in primary, secondary and tertiary healthcare settings in Islamabad, Pakistan: a cross-sectional study. Patient Prefer Adherence. 2020;14:73\u201385. https:\/\/doi.org\/10.2147\/PPA.S235517.","journal-title":"Patient Prefer Adherence"},{"issue":"7","key":"6858_CR19","doi-asserted-by":"publisher","first-page":"e030290","DOI":"10.1136\/bmjopen-2019-030290","volume":"9","author":"FJ Kinnear","year":"2019","unstructured":"Kinnear FJ, Wainwright E, Perry R, Lithander FE, Bayly G, Huntley A, et al. Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis. BMJ Open. 2019;9(7):e030290. https:\/\/doi.org\/10.1136\/bmjopen-2019-030290.","journal-title":"BMJ Open"},{"issue":"1","key":"6858_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1001\/jamainternmed.2019.4472","volume":"180","author":"N Persaud","year":"2019","unstructured":"Persaud N, Bedard M, Boozary AS, Glazier RH, Gomes T, Hwang SW, et al. Effect on treatment adherence of distributing essential medicines at no charge: the CLEAN meds randomized clinical trial. JAMA Intern Med. 2019;180(1):27\u201334.","journal-title":"JAMA Intern Med"},{"key":"6858_CR21","first-page":"24","volume":"66","author":"B Honnekeri","year":"2018","unstructured":"Honnekeri B, Rane S, Vast R, Khadilkar SV. Between the person and the pill: factors affecting medication adherence in epilepsy patients. J Assoc Physicians India. 2018;66:24.","journal-title":"J Assoc Physicians India"},{"issue":"6","key":"6858_CR22","doi-asserted-by":"publisher","first-page":"14651858","DOI":"10.1002\/14651858.CD009987.pub2","volume":"10","author":"T Kredo","year":"2013","unstructured":"Kredo T, Ford N, Adeniyi F, Garner P. Decentralizing HIV treatment in lower\u2013and\u2013middle incomes countries. Cochrane Database Syst Rev. 2013;10(6) Art No: CD009987:14651858. https:\/\/doi.org\/10.1002\/14651858.CD009987.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"6858_CR23","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/S2352-3018(16)30206-5","volume":"4","author":"S Kanters","year":"2017","unstructured":"Kanters S, Park JJ, Chan K, Socias ME, Ford N, Forrest JI, et al. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. Lancet HIV. 2017;4(1):e31\u201340. https:\/\/doi.org\/10.1016\/S2352-3018(16)30206-5.","journal-title":"Lancet HIV"},{"issue":"3","key":"6858_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/2374373518787288","volume":"6","author":"Y Krishnamoorthy","year":"2019","unstructured":"Krishnamoorthy Y, Giriyappa DK, Eliyas SK, Priyan S, Saya GK, Lakshminarayanan S. Patient and Provider\u2019s experience and perspective in addressing barriers to medication adherence among noncommunicable disease patients in rural Puducherry, South India\u2014a qualitative study. Journal of Patient Experience. 2019;6(3):216\u201323. https:\/\/doi.org\/10.1177\/2374373518787288.","journal-title":"Journal of Patient Experience"},{"issue":"10","key":"6858_CR25","doi-asserted-by":"publisher","first-page":"e0186458","DOI":"10.1371\/journal.pone.0186458","volume":"12","author":"L Nafradi","year":"2017","unstructured":"Nafradi L, Nakamoto K, Schulz PJ. Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PLoS One. 2017;12(10):e0186458. https:\/\/doi.org\/10.1371\/journal.pone.0186458.","journal-title":"PLoS One"},{"issue":"17","key":"6858_CR26","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s40265-019-01209-7","volume":"79","author":"M Leggio","year":"2019","unstructured":"Leggio M, Fusco A, Loreti C, Limongelli G, Bendini MG, Mazza A, et al. Fixed and low-dose combinations of blood pressure-lowering agents: for the many or the few? Drugs. 2019;79(17):1831\u20137. https:\/\/doi.org\/10.1007\/s40265-019-01209-7.","journal-title":"Drugs"},{"issue":"1","key":"6858_CR27","doi-asserted-by":"publisher","first-page":"e0227439","DOI":"10.1371\/journal.pone.0227439","volume":"15","author":"A Edward","year":"2020","unstructured":"Edward A, Hoffmann L, Manase F, Matsushita K, Pariyo GW, Brady TM, et al. An exploratory study on the quality of patient screening and counseling for hypertension management in Tanzania. PLoS One. 2020;15(1):e0227439. https:\/\/doi.org\/10.1371\/journal.pone.0227439.","journal-title":"PLoS One"},{"issue":"6","key":"6858_CR28","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/fampra\/13.6.522","volume":"13","author":"MN Marshall","year":"1996","unstructured":"Marshall MN. Sampling for qualitative research. Fam Pract. 1996;13(6):522\u20136. https:\/\/doi.org\/10.1093\/fampra\/13.6.522.","journal-title":"Fam Pract"},{"key":"6858_CR29","unstructured":"Krueger RA. Focus groups: A practical guide for applied research. California: Sage publications, Inc; 2014."},{"issue":"1","key":"6858_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/01406720500537304","volume":"29","author":"A Parker","year":"2006","unstructured":"Parker A, Tritter J. Focus group method and methodology: current practice and recent debate. Int J Res Method Educ. 2006;29(1):23\u201337. https:\/\/doi.org\/10.1080\/01406720500537304.","journal-title":"Int J Res Method Educ"},{"issue":"1","key":"6858_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/2041-210X.12860","volume":"9","author":"O Nyumba T","year":"2018","unstructured":"Nyumba T O, Wilson K, Derrick CJ, Mukherjee N. The use of focus group discussion methodology: insights from two decades of application in conservation. Methods Ecol Evol. 2018;9(1):20\u201332. https:\/\/doi.org\/10.1111\/2041-210X.12860.","journal-title":"Methods Ecol Evol"},{"issue":"3","key":"6858_CR32","doi-asserted-by":"publisher","first-page":"e0192603","DOI":"10.1371\/journal.pone.0192603","volume":"13","author":"A Wollum","year":"2018","unstructured":"Wollum A, Gabert R, McNellan CR, Daly JM, Reddy P, Bhatt P, et al. Identifying gaps in the continuum of care for cardiovascular disease and diabetes in two communities in South Africa: baseline findings from the HealthRise project. PLoS One. 2018;13(3):e0192603. https:\/\/doi.org\/10.1371\/journal.pone.0192603.","journal-title":"PLoS One"},{"issue":"4","key":"6858_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2648.2004.03207.x","volume":"48","author":"GA Tobin","year":"2004","unstructured":"Tobin GA, Begley CM. Methodological rigour within a qualitative framework. J Adv Nurs. 2004;48(4):388\u201396. https:\/\/doi.org\/10.1111\/j.1365-2648.2004.03207.x.","journal-title":"J Adv Nurs"},{"issue":"1","key":"6858_CR34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12913-014-0624-z","volume":"14","author":"AO Odusola","year":"2014","unstructured":"Odusola AO, Hendriks M, Schultsz C, Bolarinwa OA, Akande T, Osibogun A, et al. Perceptions of inhibitors and facilitators for adhering to hypertension treatment among insured patients in rural Nigeria: a qualitative study. BMC Health Serv Res. 2014;14(1):624. https:\/\/doi.org\/10.1186\/s12913-014-0624-z.","journal-title":"BMC Health Serv Res"},{"key":"6858_CR35","unstructured":"Corbin J, Strauss A. Basics of qualitative research: techniques and procedures for developing grounded theory. California: Sage publications; 2014."},{"key":"6858_CR36","volume-title":"SAGE open medicine","author":"TY Chun","year":"2019","unstructured":"Chun TY, Birks M, Francis K. Grounded theory research: a design framework for novice researchers. In: SAGE open medicine; 2019."},{"issue":"4","key":"6858_CR37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/bcp.14240","volume":"86","author":"L Eliasson","year":"2020","unstructured":"Eliasson L, Clifford S, Mulick A, Jackson C, Vrijens B. How the EMERGE guideline on medication adherence can improve the quality of clinical trials. Br J Clin Pharmacol. 2020;86(4):687\u201397. https:\/\/doi.org\/10.1111\/bcp.14240.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"6858_CR38","doi-asserted-by":"publisher","first-page":"29041","DOI":"10.3402\/gha.v9.29041","volume":"9","author":"AO Odusola","year":"2016","unstructured":"Odusola AO, Stronks K, Hendriks ME, Schultsz C, Akande T, Osibogun A, et al. Enablers and barriers for implementing high-quality hypertension care in a rural primary care setting in Nigeria: perspectives of primary care staff and health insurance managers. Glob Health Action. 2016;9(1):29041. https:\/\/doi.org\/10.3402\/gha.v9.29041.","journal-title":"Glob Health Action"},{"issue":"8","key":"6858_CR39","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1751-7176.2008.08329.x","volume":"10","author":"G Ogedegbe","year":"2008","unstructured":"Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens. 2008;10(8):644\u20136. https:\/\/doi.org\/10.1111\/j.1751-7176.2008.08329.x.","journal-title":"J Clin Hypertens"},{"issue":"4","key":"6858_CR40","first-page":"349","volume":"41","author":"AD Adedapo","year":"2012","unstructured":"Adedapo AD, Sikuade O, Adeleke S, Okechukwu R. Drug utilization and blood pressure control in a population where antihypertensives are given free: effect of policy change. Afr J Med Med Sci. 2012;41(4):349\u201356.","journal-title":"Afr J Med Med Sci"},{"issue":"10","key":"6858_CR41","doi-asserted-by":"publisher","first-page":"529","DOI":"10.4314\/eamj.v80i10.8756","volume":"80","author":"BL Salako","year":"2003","unstructured":"Salako BL, Ajose FA, Lawani E. Blood pressure control in a population where antihypertensives are given free. East Afr Med J. 2003;80(10):529\u201331. https:\/\/doi.org\/10.4314\/eamj.v80i10.8756.","journal-title":"East Afr Med J"},{"issue":"3","key":"6858_CR42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0749-3797(01)00356-7","volume":"21","author":"LE Boulware","year":"2001","unstructured":"Boulware LE, Daumit GL, Frick KD, Minkovitz CS, Lawrence RS, Powe NR. An evidence-based review of patient-centered behavioral interventions for hypertension. Am J Prev Med. 2001;21(3):221\u201332. https:\/\/doi.org\/10.1016\/S0749-3797(01)00356-7.","journal-title":"Am J Prev Med"},{"issue":"1","key":"6858_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12872-020-01370-y","volume":"20","author":"DE Okai","year":"2020","unstructured":"Okai DE, Manu A, Amoah EM, Laar A, Akamah J, Torpey K. Patient-level factors influencing hypertension control in adults in Accra, Ghana. BMC Cardiovasc Disord. 2020;20(1):123. https:\/\/doi.org\/10.1186\/s12872-020-01370-y.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"6858_CR44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/01.hco.0000231400.10104.e2","volume":"21","author":"G Harmon","year":"2006","unstructured":"Harmon G, Lefante J, Krousel-Wood M. Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications. Curr Opin Cardiol. 2006;21(4):310\u20135. https:\/\/doi.org\/10.1097\/01.hco.0000231400.10104.e2.","journal-title":"Curr Opin Cardiol"},{"issue":"1","key":"6858_CR45","doi-asserted-by":"publisher","first-page":"25028","DOI":"10.3402\/gha.v7.25028","volume":"7","author":"MA Khanam","year":"2014","unstructured":"Khanam MA, Lindeboom W, Koehlmoos TL, Alam DS, Niessen L, Milton AH. Hypertension: adherence to treatment in rural Bangladesh--findings from a population-based study. Glob Health Action. 2014;7(1):25028. https:\/\/doi.org\/10.3402\/gha.v7.25028.","journal-title":"Glob Health Action"},{"issue":"12","key":"6858_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11906-015-0606-5","volume":"17","author":"VS Conn","year":"2015","unstructured":"Conn VS, Ruppar TM, Chase J-AD, Enriquez M, Cooper PS. Interventions to improve medication adherence in hypertensive patients: systematic review and Meta-analysis. Curr Hypertens Rep. 2015;17(12):94. https:\/\/doi.org\/10.1007\/s11906-015-0606-5.","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"6858_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1532-5415.2009.02639.x","volume":"58","author":"MA Krousel-Wood","year":"2010","unstructured":"Krousel-Wood MA, Muntner P, Joyce CJ, Islam T, Stanley E, Holt EW, et al. Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc. 2010;58(1):54\u201361. https:\/\/doi.org\/10.1111\/j.1532-5415.2009.02639.x.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"6858_CR48","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/jch.12105","volume":"15","author":"JR Turner","year":"2013","unstructured":"Turner JR. Patient and physician adherence in hypertension management. J Clin Hypertens. 2013;15(7):447\u201352. https:\/\/doi.org\/10.1111\/jch.12105.","journal-title":"J Clin Hypertens"},{"key":"6858_CR49","doi-asserted-by":"crossref","unstructured":"Mbuya FE, Fredrick F, Kundi B. Knowledge of diabetes and hypertension among members of teaching staff of higher learning institutions in Dar es Salaam, Tanzania. Tanzania J Health Res. 2014;16(2):98-103","DOI":"10.4314\/thrb.v16i2.5"},{"issue":"3","key":"6858_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/jch.12646","volume":"18","author":"J Maginga","year":"2016","unstructured":"Maginga J, Guerrero M, Koh E, Holm Hansen C, Shedafa R, Kalokola F, et al. Hypertension control and its correlates among adults attending a hypertension clinic in Tanzania. J Clin Hypertens. 2016;18(3):207\u201316. https:\/\/doi.org\/10.1111\/jch.12646.","journal-title":"J Clin Hypertens"},{"issue":"9755","key":"6858_CR51","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/S0140-6736(10)61997-6","volume":"376","author":"RT Lester","year":"2010","unstructured":"Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(10)61997-6.","journal-title":"Lancet"},{"issue":"6","key":"6858_CR52","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/QAD.0b013e32834380c1","volume":"25","author":"C Pop-Eleches","year":"2011","unstructured":"Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, De Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS (London, England). 2011;25(6):825.","journal-title":"AIDS (London, England)"},{"key":"6858_CR53","doi-asserted-by":"publisher","unstructured":"Horvath T, Azman H, Kennedy GE, Rutherford GW. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev. 2012;2012(3):CD009756. https:\/\/doi.org\/10.1002\/14651858.CD009756.","DOI":"10.1002\/14651858.CD009756"},{"issue":"12","key":"6858_CR54","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1089\/tmj.2019.0305","volume":"26","author":"AC Sartori","year":"2020","unstructured":"Sartori AC, Rodrigues Lucena TF, Takao Lopes C, Picinin Bernuci M, Yamaguchi MU. Educational intervention using WhatsApp on medication adherence in hypertension and diabetes patients: a randomized clinical trial. Telemed J E Health. 2020;26(12):1526\u201332. https:\/\/doi.org\/10.1089\/tmj.2019.0305.","journal-title":"Telemed J E Health"},{"issue":"1","key":"6858_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13690-021-00594-4","volume":"79","author":"NA Azadi","year":"2021","unstructured":"Azadi NA, Ziapour A, Lebni JY, Irandoost SF, Abbas J, Chaboksavar F. The effect of education based on health belief model on promoting preventive behaviors of hypertensive disease in staff of the Iran University of Medical Sciences. Arch Public Health = Archives belges de sante publique. 2021;79(1):69.","journal-title":"Arch Public Health = Archives belges de sante publique"},{"issue":"9938","key":"6858_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0140-6736(14)61091-6","volume":"384","author":"R Beaglehole","year":"2014","unstructured":"Beaglehole R, Bonita R, Ezzati M, Alleyne G, Dain K, Kishore SP, et al. NCD countdown 2025: accountability for the 25\u00d7 25 NCD mortality reduction target. Lancet. 2014;384(9938):105\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(14)61091-6.","journal-title":"Lancet"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-06858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-021-06858-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-06858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T08:07:25Z","timestamp":1629274045000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-021-06858-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6858"],"URL":"https:\/\/doi.org\/10.1186\/s12913-021-06858-7","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"assertion":[{"value":"20 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study obtained IRB approval from the National Institute of Medical Research Institute, Tanzania. It was deemed \u2018Exempt Human Subjects Research\u2019 by the Johns Hopkins Bloomberg School of Public Health IRB. Informed consent was obtained from the health providers who participated in the KIIs and from the patients who participated in the focus group discussions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"834"}}